Search
Advanced Search

Concentrate Of Human Coagulation Factor Viii Containing Von Willebrand Factor For The Treatment Of Von Willebrand Disease, In A Ratio Of At Least 1 Unit Of Von Willebrand Factor To 1 Unit Of Coagulation Factor Viii, Together With Delivery To Regional Blood Donation And Blood Treatment Centers, Parts: 1÷2; Procedure Reference: Zzp.Zp.411.90.2024

ca

General Information
   Oct 15, 2024
   Polish
   Other
   published: Oct 15, 2024

Original Text

TED 00622347-2024 - Result















Help Print Share





Share ×

Facebook X/Twitter LinkedIn Email

Cancel





.ted-toolbar {
display: flex;
}

.ted-mini-toolbar {
display: flex;
margin-bottom: 22px;
margin-left: auto;
}

.ted-help,
.ted-download,
.ted-print,
.ted-social-share {
background: none;
border: none;...
Subscription Options

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact Us

Contract award information
   Asclepios S.A. Asclepios S.A.
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.